Your browser doesn't support javascript.
loading
Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies.
Monjazeb, Arta M; Kent, Michael S; Grossenbacher, Steven K; Mall, Christine; Zamora, Anthony E; Mirsoian, Annie; Chen, Mingyi; Kol, Amir; Shiao, Stephen L; Reddy, Abhinav; Perks, Julian R; T N Culp, William; Sparger, Ellen E; Canter, Robert J; Sckisel, Gail D; Murphy, William J.
Afiliación
  • Monjazeb AM; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California. ammonjazeb@ucdavis.edu.
  • Kent MS; Department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine, Davis, California.
  • Grossenbacher SK; Department of Dermatology, UC Davis Health Sciences, Sacramento, California.
  • Mall C; Department of Dermatology, UC Davis Health Sciences, Sacramento, California.
  • Zamora AE; Department of Dermatology, UC Davis Health Sciences, Sacramento, California.
  • Mirsoian A; Department of Dermatology, UC Davis Health Sciences, Sacramento, California.
  • Chen M; Department of Pathology, UC Davis Health Sciences, Sacramento, California.
  • Kol A; Department of Pathology, Microbiology, and Immunology, UC Davis School of Veterinary Medicine, Davis, California.
  • Shiao SL; Departments of Radiation Oncology and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Reddy A; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California.
  • Perks JR; Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California.
  • T N Culp W; Department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine, Davis, California.
  • Sparger EE; Department of Surgical and Radiological Sciences, UC Davis School of Veterinary Medicine, Davis, California.
  • Canter RJ; Division of Surgical Oncology, Department of Surgery, UC Davis Comprehensive Cancer Center, Sacramento, California.
  • Sckisel GD; Department of Dermatology, UC Davis Health Sciences, Sacramento, California.
  • Murphy WJ; Department of Dermatology, UC Davis Health Sciences, Sacramento, California. Division of Hematology and Oncology, Department of Internal Medicine, UC Davis Comprehensive Cancer Center, Sacramento, California.
Clin Cancer Res ; 22(17): 4328-40, 2016 Sep 01.
Article en En | MEDLINE | ID: mdl-26979392
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Inmunosupresión / Indolamina-Pirrol 2,3,-Dioxigenasa / Inmunomodulación / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Inmunosupresión / Indolamina-Pirrol 2,3,-Dioxigenasa / Inmunomodulación / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos